These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 452638)

  • 1. [Kallikrein activity and non-specific esterolytic activity of proteases in experimental hemorrhagic shock of varying duration and depth].
    Kühne H; Scheuch DW
    Z Med Lab Diagn; 1979 Feb; 20(1):20-3. PubMed ID: 452638
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of plasma kallikrein and protease activities in hemorrhagic shock of the dog].
    Kühne H; Scheuch DW
    Z Med Lab Diagn; 1977 Jun; 18(3):169-76. PubMed ID: 899160
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characterization of shock sensitivity in experimental hemorrhagic shock (5,3 and 8,0 kPa) by determining kallikrein, kallikreinogen, non-specific proteases and inhibitor capacity of blood plasma].
    Kühne H; Lehmann B; Taucher M; Scheuch DW
    Z Med Lab Diagn; 1983; 24(3):123-8. PubMed ID: 6351457
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kallikrein activity and the inhibitory capacity of the blood plasma in experimental hemorrhagic shock in dogs].
    Kühne H; Lehmann B; Scheuch DW
    Khirurgiia (Sofiia); 1979; 32(4):273-8. PubMed ID: 316041
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs.
    Aasen AO; Frolich W; Saugstad OD; Amundsen E
    Eur Surg Res; 1978; 10(1):50-62. PubMed ID: 344043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition capacity of serum for proteolytic enzymes during massive hemorrhages and in the pathogenesis of shock].
    Duck HJ; Ebeling K; Wagner J
    Z Gesamte Inn Med; 1971 Jun; 26(12):Suppl:147-51. PubMed ID: 5122593
    [No Abstract]   [Full Text] [Related]  

  • 7. [The kallikrein-kinin system and shock].
    Kühne H; Scheuch DW
    Z Med Lab Diagn; 1982 Apr; 23(2):75-84. PubMed ID: 6921924
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kallikrein and protease activity in the plasma of shock syndrome patients].
    Kühne H; Mecke B; Scheuch DW
    Khirurgiia (Sofiia); 1980; 33(5):385-9. PubMed ID: 7003215
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspects of plasma proteolysis in lethal canine endotoxin shock.
    Aasen AO; Amundsen E
    Acta Chir Scand Suppl; 1982; 509():23-31. PubMed ID: 6762028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory capacity of the serum toward proteolytic enzymes during massive hemorrhage and in the pathogenesis of shock].
    Duck HJ; Ebeling K; Wagner J
    Z Gesamte Inn Med; 1971 Jun; 26(12):Suppl:147-51. PubMed ID: 5570303
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chromatographic separation of activated proteases from human plasma].
    Lehmann B; Taucher M; Kühne H; Scheuch DW
    Biomed Biochim Acta; 1988; 47(4-5):363-71. PubMed ID: 2467663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversibility in shock: role of vasoactive kinins.
    Massion WH; Blümel G
    Anesth Analg; 1971; 50(6):970-6. PubMed ID: 5316075
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of various parameters of the kallikrein-kinin-system in experimental shock and different types of shock sensitivity].
    Kühne H; Lehmann B; Scheuch DW
    Z Med Lab Diagn; 1981; 22(5):258-63. PubMed ID: 6917645
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of trypsin, kallikrein and kontrikal on the enzyme activity and cationic protein content of the blood neutrophils].
    Kharchenko VZ; Protsenko VA; Shpak SI; Kolbasin PN
    Farmakol Toksikol; 1986; 49(2):24-6. PubMed ID: 2423365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ornithine carbamoyltransferase activity in experimental hemorrhagic shock in dogs].
    Riemert C; Häcker R; Scheuch DW
    Z Med Lab Diagn; 1978 Aug; 19(4):218-22. PubMed ID: 716542
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characterization of the enzyme activity change kinetics in blood plasma in experimental hemorrhagic stock].
    Kopprasch S; Orlik H; Scheuch DW
    Z Med Lab Diagn; 1982 Jun; 23(3):204-6. PubMed ID: 7136171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the proteolytic activity and components of the blood kallikrein-kinin system during the growth and metastasis of experimental neoplasms].
    Veksler IG; Veremeenko KN; Riabukha VN; Pogorelaia NF; Balitskiĭ KP
    Eksp Onkol; 1986; 8(3):65-7. PubMed ID: 3522198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of kallikrein-kinin system activation by factor XII f pretreatment on experimental hemorrhagic shock.
    Taucher M; Grässler J; Kühne H; Scheuch DW
    Z Med Lab Diagn; 1990; 31(1):13-7. PubMed ID: 2330739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity changes of indicator enzymes in plasma in relation to severity of experimental hemorrhagic shock in the dog].
    Orlik H; Schaper U; Scholz M; Scheuch DW
    Z Med Lab Diagn; 1980; 21(1):18-25. PubMed ID: 7405350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.